ClinicalTrials.govpublic full text
Sorafenib in Resected Non-small Cell Lung Carcinoma
carcinoma, non-small-cell lung, sorafenib, nsclc, adjuvant treatment, resected non-small cell lung carcinoma, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 913026
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.